AbbVie’s telisotuzumab adizutecan achieved an ORR of 63% in EGFR-mutant NSCLC patients, with current ADC options in this ...

Whether they’re suffering from red, itchy eyes during allergy season, dealing with the discomfort of ear wax buildup or ...

Introduction: The global botulinum toxin market has evolved from being a beauty-industry phenomenon to becoming a ...

$1.5 million is the 'magic number' for retirement savings—here's how long it lasts in every U.S. state ...

CollPlant Biotechnologies , a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived, rhCollagen for tissue regeneration and ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway Inc. (BRK.B), ...

Everhome Suites, the midscale extended stay brand from Choice Hotels International, Inc. (NYSE: CHH), continues to grow its ...

The growth in the historical period was largely attributed to the increasing prevalence of pelvic cancers, the aging population, the rise in cervical cancer cases, government initiatives, and ...